Literature DB >> 9006732

Treatment of radioiodine-negative bone metastasis from papillary thyroid carcinoma with percutaneous ethanol injection therapy.

K Nakada1, K Kasai, Y Watanabe, C Katoh, K Kanegae, E Tsukamoto, K Itoh, N Tamaki.   

Abstract

A 62-year-old woman with metastatic papillary thyroid carcinoma in the sternum was successfully treated with percutaneous ethanol injection therapy (PET) when previous radioiodine therapy and external irradiation were ineffective. The patient tolerated the treatment well and the refractory pain in the anterior chest wall that was alleviated with morphine prior to PEIT completely disappeared. No severe complications were observed. PEIT was performed 4 times (2 times with ultrasound guidance and 2 times with CT guidance). The posttreatment CT scan and 201Tl scintigraphy demonstrated significant decrease in the tumor volume. The serum thyroglobulin level fell to less than one-twentieth of the pretreatment value. It is suggested that PEIT has a value in treating bone metastasis from thyroid carcinoma which do not respond to radioiodine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9006732     DOI: 10.1007/bf03164808

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

1.  Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules.

Authors:  E Martino; M L Murtas; A Loviselli; M Piga; L Petrini; P Miccoli; F Pacini
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

2.  Percutaneous ethanol injection therapy for autonomously functioning thyroid nodule.

Authors:  K Nakada; C Katoh; K Kanegae; E Tsukamoto; K Itoh; N Tamaki
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

3.  Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases.

Authors:  J K Harness; N W Thompson; J C Sisson; W H Beierwaltes
Journal:  Arch Surg       Date:  1974-04

4.  Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation.

Authors:  F Monzani; O Goletti; N Caraccio; P Del Guerra; M Ferdeghini; E Pucci; L Baschieri
Journal:  Clin Endocrinol (Oxf)       Date:  1992-05       Impact factor: 3.478

5.  Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.

Authors:  A P Brown; W P Greening; V R McCready; H J Shaw; C L Harmer
Journal:  Br J Radiol       Date:  1984-04       Impact factor: 3.039

6.  Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment.

Authors:  J P Massin; J C Savoie; H Garnier; G Guiraudon; F A Leger; F Bacourt
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

7.  Percutaneous injection of ethanol to treat autonomous thyroid nodules.

Authors:  S Mazzeo; M G Toni; C De Gaudio; D Caramella; F Pinto; R Lencioni; F Sanguinetti; C Bartolozzi
Journal:  AJR Am J Roentgenol       Date:  1993-10       Impact factor: 3.959

8.  External irradiation for malignant thyroid tumors.

Authors:  C T Chung; R H Sagerman; M C Ryoo; G A King; W S Yu; P S Dalal; I G Emmanuel
Journal:  Radiology       Date:  1980-09       Impact factor: 11.105

  8 in total
  2 in total

1.  Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.

Authors:  Valeria Carina; Viviana Costa; Stefania Pagani; Angela De Luca; Lavinia Raimondi; Daniele Bellavia; Stefania Setti; Milena Fini; Gianluca Giavaresi
Journal:  J Exp Clin Cancer Res       Date:  2018-08-20

2.  New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: literature review.

Authors:  Kai-Pun Wong; Brian Hung-Hin Lang
Journal:  J Thyroid Res       Date:  2012-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.